ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

Single Center Experience with Long-Term Prospective BK Monitoring in Renal Transplantation

J. Trofe-Clark, D. Sawinski, T. Sparkes, S. Goral, M. Bleicher, R. Bloom

Pharmacy, Hospital of Univ of Pennsylvania, Philadelphia
Renal, Perelman School of Medicine, Univ of Pennsylvania, Philadelphia, PA

Meeting: 2013 American Transplant Congress

Abstract number: C1360

Related Abstracts
  • Long Term Outcomes and Quality of Life of Live Liver Donors. A Single Center Experience
  • Excellent Long-Term Outcome of ABO-Incompatible Living Donor Kidney Transplantation; a Single Center Experience for over 20 Years

Prospective screening for BK viremia (BKV) in renal transplant recipients (RTR) may allow earlier detection of BKV reactivation and prevent BKV nephropathy (BKVN). However, utility of long term screening is unknown. Purpose: To determine the incidence and time to BKV with use of protocolized BKV screening. Methods: In Jan 2008, we implemented quantitative BKV plasma screening for all RTR (including kidney-pancreas) patients (pts) at 3,6 and 12 months (mos) then yearly. Detectable BKV was defined as ≥ 2.6 log copies/mL. BKVN was defined as biopsy light microscopy changes consistent with BKVN, positive VP-1 capsid and SV40 immunostaining. RTR received induction with rabbit anti-thymocyte globulin (majority of pts), or basiliximab (low-immunologic risk pts) and maintenance w/ tacrolimus (TAC), mycophenolate mofetil (MMF) and steroids. MMF was discontinued upon BKV detection, followed by TAC dose decrease if BKV persisted. Biopsies were only performed for graft dysfunction. Retrospective analysis was performed for any RTR transplanted Jan 2008-December 2011 who had ≥1 BKV load drawn until June 2012 at a protocol time-point. Results: 622/691 (90%) RTR pts had BKV screening with ≥ 1 value by protocol [473 values at 3 mos, 448 at 6 mos, 394 at 12 mos, 171 at 24 mos, 92 at 36 mos and 10 at 48 mos]. At least 1 BKV ≥ 2.6 log copies/mL occurred in 106 (17%) pts.

Time of First BKV Detection ≥ 2.6 log copies/mL at Protocol Time-Point
3 months 51 (48%)
6 months 34 (32%)
12 months 18 (17%)
24 months 1 (0.9%)
36 months 2 (2%)
48 months None

A pt with first BKV detected at 24 mos had a negative screen at 12 mos. Two pts first detected at 36 mos had negative screens at 3 and 24 mos respectively. BKV detection/RTR yr for screened pts was: 28 (19%) in 2008, 31 (18%) in 2009, 27(19%) in 2010 and 20 (13%) in 2011 (screened until June 2012). BKVN occurred in 8 pts (1%) during the screening period. Median time to BKVN was 6.5 (2-12 mos) post- transplant and 7/8 (88%) pts had BKV >4.0 log copies/mL at diagnosis. Conclusions: Detection of BKV rates of ≥ 2.6 log copies/mL/year remained consistent from 2008-2010 and BKVN rates remained low. BKV ≥ 2.6 log copies/mL were most often detected at the 3 mo screen. New onset BKV at ≥ 24 mos was rare, questioning the utility of protocol screening beyond 12-24 mos unless renal dysfunction is present. Follow-up is ongoing.

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Trofe-Clark J, Sawinski D, Sparkes T, Goral S, Bleicher M, Bloom R. Single Center Experience with Long-Term Prospective BK Monitoring in Renal Transplantation [abstract]. Am J Transplant. 2013; 13 (suppl 5). https://atcmeetingabstracts.com/abstract/single-center-experience-with-long-term-prospective-bk-monitoring-in-renal-transplantation/. Accessed January 27, 2021.

« Back to 2013 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Penis Transplantation: First U.S. Experience.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Live Related Kidney Transplant Experience in Abuja, Nigeria – First Eight Cases Ever.
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Penis Transplantation: First U.S. Experience.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Live Related Kidney Transplant Experience in Abuja, Nigeria – First Eight Cases Ever.

    Visit Our Partner Sites

    American Transplant Congress (ATC)

    Visit the official site for the American Transplant Congress »

    American Journal of Transplantation

    The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

    American Society of Transplantation (AST)

    An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

    American Society of Transplant Surgeons (ASTS)

    The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

    Copyright © 2013-2021 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

    Privacy Policy

    loading Cancel
    Post was not sent - check your email addresses!
    Email check failed, please try again
    Sorry, your blog cannot share posts by email.
    This site uses cookies: Find out more.